Talis Biomedical
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Talis Biomedical's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 89% to $412,000. The net income raised on -$62,007,000 and profit margin reached -15050%. Total operating expenses were $67,186,000.
Profit Margin
| 2018 | 2.39M | -21.33M | -892.76% |
|---|---|---|---|
| 2019 | 3.97M | -27.43M | -689.77% |
| 2020 | 10.93M | -91.07M | -832.66% |
| 2021 | 0 | -190.45M | |
| 2022 | 3.65M | -110.88M | -3036.28% |
| 2023 | 412K | -62.00M | -15050.24% |
TLIS Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 412K | 3.65M | 0 | 10.93M | 3.97M | 2.39M |
Cost of revenue | 41K | 8.39M | 2.62M | 0 | 0 | 0 |
Gross profit | 371K | -4.73M | -2.62M | 10.93M | 3.97M | 2.39M |
Operating exp. | ||||||
Research and development | 40.69M | 70.83M | 157.59M | 89.01M | 23.81M | 18.38M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 67.18M | 110.4M | 191.81M | 91.18M | 26.69M | 21.43M |
Operating income | -66.81M | -115.13M | -191.81M | -91.18M | -26.69M | -21.43M |
Other income (expenses), net | 4.80M | 2.12M | -220K | 54K | -775K | 93K |
Income before tax | -62.00M | -113.01M | -192.03M | -91.13M | -27.47M | -21.33M |
Income tax expense | 0 | -2.12M | -1.57M | -54K | -42K | 93K |
Net income | -62.00M | -110.88M | -190.45M | -91.07M | -27.43M | -21.33M |
Earnings per share | ||||||
Basic EPS | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
Diluted EPS | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
| Data source | Data source | Data source | Data source |